/BIIO
BIIO Stock - Bionovate Technologies Corp
Healthcare|Medical - DevicesOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
47
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BIIO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta8.96
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | $5,386 |
| Gross Profit | N/A | N/A | N/A | N/A | $906 |
| Gross Margin | N/A | N/A | N/A | N/A | 16.8% |
| Operating Income | $-45,371 | $-33,055 | $-56,543 | $-118,877 | $-87,734 |
| Net Income | $-106,544 | $-122,045 | $-208,896 | $-1,740,736 | $-323,313 |
| Net Margin | N/A | N/A | N/A | N/A | -6002.8% |
| EPS | $-0.00 | $-0.00 | $-1.34 | $-27.63 | $-1.09 |
Company Overview
Bionovate Technologies Corp., a medical device company, focuses on developing automated treatment for age spots. It intends to develop automated computerized system that treats age spots anywhere on the body. The company targets to sell its systems to physicians and spas worldwide. The company was formerly known as MJP International Ltd. and changed its name to Bionovate Technologies Corp. in December 2017. Bionovate Technologies Corp. was founded in 2010 and is based in Cham, Switzerland. As of October 7, 2020, Bionovate Technologies Corp. operates as a subsidiary of Human Data AG.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
BIIOBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q3 2021
EPS Surprise History
Q4 19
No data
Q1 20
No data
Q2 20
No data
Q3 20
No data
Q4 20
No data
Q1 21
No data
Q2 21
No data
Q3 21
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2021 | Sep 30, 2021 | — | $-0.00 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.00 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.00 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.00 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.00 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.00 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.00 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.29 | — | — |
Q3 2019 | Sep 30, 2019 | — | $-0.19 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.31 | — | — |
Q1 2019 | Mar 31, 2019 | — | $-0.16 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.30 | — | — |
Q3 2018 | Sep 30, 2018 | — | $-0.56 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.66 | — | — |
Q1 2018 | Mar 31, 2018 | — | $-16.68 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-0.15 | — | — |
Q3 2017 | Sep 30, 2017 | — | $-0.11 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-1249.65 | — | — |
Q1 2017 | Mar 31, 2017 | — | $-0.17 | — | — |
Q4 2016 | Dec 31, 2016 | — | $10.60 | — | — |
Latest News
Loading news...
Frequently Asked Questions about BIIO
What is BIIO's current stock price?
Bionovate Technologies Corp (BIIO) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for BIIO?
No analyst price targets are currently available for this stock.
What sector is Bionovate Technologies Corp in?
Bionovate Technologies Corp operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is BIIO's market cap?
Bionovate Technologies Corp has a market capitalization of $0.00 billion, making it a small-cap company.
Does BIIO pay dividends?
No, Bionovate Technologies Corp does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAMHD
HLK Biotech Holding Group, Inc.
$0.00
Mkt Cap: $0.0B
ATRX
Adhera Therapeutics, Inc.
$0.00
Mkt Cap: $0.0B
LITH
BioELife Corp.
$0.00
Mkt Cap: $0.0B
MMTC
Micro Imaging Technology, Inc.
$0.00
Mkt Cap: $0.0B
MOTS
Motus GI Holdings, Inc.
$0.00
Mkt Cap: $0.0B
OTRKQ
Ontrak, Inc.
$0.00
Mkt Cap: $0.0B
PJET
Priority Aviation, Inc.
$0.00
Mkt Cap: $0.0B
PROT
Proteonomix, Inc.
$0.00
Mkt Cap: $0.0B
ROSGQ
Rosetta Genomics Ltd.
$0.00
Mkt Cap: $0.0B
UTRS
Minerva Surgical, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to BIIO for comparison